ANPEP and infection: Both soluble hAPN and antibody 9.8E12 can inhibit HCoV–229E infection in a cell-based assay, an indication that their binding energies (Kd of 430 and 66 nM, respectively) are sufficient to efficiently overcome the barrier to binding.